Evidence Summary
- Evidence Level
- Moderate
- Mechanism
- Anti-inflammatory, Enrollment: Actual, Immunomodulatory, Neurological / Autonomic
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 5 study reference(s) in current data. Review primary sources and consult specialists before use.
Clinical Trials
2 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT06305780 | RECOVER-AUTONOMIC Platform Protocol | Phase 2 | Completed |
| NCT06305793 | RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) | Phase 2 | Completed |